Investors in UroGen Pharma Ltd. (URGN): Protect Your Rights – Contact Levi & Korsinsky Before July 28, 2025
NEW YORK, NY / ACCESS Newswire / June 10, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/urogen-pharma-ltd-lawsuit-submission-form?prid=152499&wire=1&utm_campaign=11 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or […]